|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donepudi MS, Kondapalli K, Amos SJ and
Venkanteshan P: Breast cancer statistics and markers. J Cancer Res
Ther. 10:506–511. 2014.PubMed/NCBI
|
|
3
|
Abels JC, Gorham AT, Pack GT and Rhoads
CP: Metabolic studies in patients with cancer of the
gastro-intestinal tract. I. Plasma vitamin A levels in patients
with malignant neoplastic disease, particularly of the
gastro-intestinal tract. J Clin Invest. 20:749–764. 1941.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peitzsch C, Kurth I, Kunz-Schughart L,
Baumann M and Dubrovska A: Discovery of the cancer stem cell
related determinants of radioresistance. Radiother Oncol.
108:378–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rich JN: Cancer stem cells in radiation
resistance. Cancer Res. 67:8980–8984. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pajonk F, Vlashi E and McBride WH:
Radiation resistance of cancer stem cells: The 4 R's of
radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y,
Zhang J, Yuan J, Wang M, Chen D, Sun Y, et al: ATM-mediated
stabilization of ZEB1 promotes DNA damage response and
radioresistance through CHK1. Nat Cell Biol. 16:864–875. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: OncomiRs: The potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ: OncomiRs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar :
|
|
12
|
Nana-Sinkam SP and Croce CM: MicroRNA
regulation of tumorigenesis, cancer progression and interpatient
heterogeneity: Towards clinical use. Genome Biol. 15:4452014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou W, Shi G, Zhang Q, Wu Q, Li B and
Zhang Z: MicroRNA-20b promotes cell growth of breast cancer cells
partly via targeting phosphatase and tensin homologue (PTEN). Cell
Biosci. 4:622014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Xiao B, Tong H, Xie F, Zhang Z and
Xiao GG: Regulation of breast cancer tumorigenesis and metastasis
by miRNAs. Expert Rev Proteomics. 9:615–625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
16
|
Huang X, Taeb S, Jahangiri S, Emmenegger
U, Tran E, Bruce J, Mesci A, Korpela E, Vesprini D, Wong CS, et al:
miRNA-95 mediates radioresistance in tumors by targeting the
sphingolipid phosphatase SGPP1. Cancer Res. 73:6972–6986. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kato M, Paranjape T, Müller RU, Nallur S,
Gillespie E, Keane K, Esquela-Kerscher A, Weidhaas JB and Slack FJ:
The miR-34 microRNA is required for the DNA damage response in vivo
in C. elegans and in vitro in human breast cancer cells. Oncogene.
28:2419–2424. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Keller A, Leidinger P, Vogel B, Backes C,
ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick
R, et al: miRNAs can be generally associated with human pathologies
as exemplified for miR-144. BMC Med. 12:2242014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Qin X, Sun Q, Guo H, Wu X, Xie F,
Xu Q, Yan M, Liu J, Han Z, et al: Transcriptional control of
PAX4-regulated miR-144/451 modulates metastasis by suppressing
ADAMs expression. Oncogene. 34:3283–3295. 2015. View Article : Google Scholar
|
|
20
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakshatri H: Radiation resistance in
breast cancer: Are CD44+/CD24−/proteosome
low/PKH26+ cells to blame? Breast Cancer Res.
12:1052010. View
Article : Google Scholar
|
|
22
|
Tessner TG, Muhale F, Riehl TE, Anant S
and Stenson WF: Prostaglandin E2 reduces radiation-induced
epithelial apoptosis through a mechanism involving AKT activation
and bax translocation. J Clin Invest. 114:1676–1685. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cellini F, Morganti AG, Genovesi D,
Silvestris N and Valentini V: Role of microRNA in response to
ionizing radiations: Evidences and potential impact on clinical
practice for radiotherapy. Molecules. 19:5379–5401. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iwaya T, Yokobori T, Nishida N, Kogo R,
Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et
al: Downregulation of miR-144 is associated with colorectal cancer
progression via activation of mTOR signaling pathway.
Carcinogenesis. 33:2391–2397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang
Z, Qiu F and Lin J: miR-144 downregulation increases bladder cancer
cell proliferation by targeting EZH2 and regulating Wnt signaling.
FEBS J. 280:4531–4538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buffa FM, Camps C, Winchester L, Snell CE,
Gee HE, Sheldon H, Taylor M, Harris AL and Ragoussis J:
microRNA-associated progression pathways and potential therapeutic
targets identified by integrated mRNA and microRNA expression
profiling in breast cancer. Cancer Res. 71:5635–5645. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McAllister SD, Murase R, Christian RT, Lau
D, Zielinski AJ, Allison J, Almanza C, Pakdel A, Lee J, Limbad C,
et al: Pathways mediating the effects of cannabidiol on the
reduction of breast cancer cell proliferation, invasion, and
metastasis. Breast Cancer Res Treat. 129:37–47. 2011. View Article : Google Scholar
|
|
28
|
Webb CP and Vande Woude GF: Genes that
regulate metastasis and angiogenesis. J Neurooncol. 50:71–87. 2000.
View Article : Google Scholar
|
|
29
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang WT, Cheng ZY, Jia ZQ and Wang BY:
PTEN: A new target in inhibiting of tumor invasion and metastasis.
Sheng Li Ke Xue Jin Zhan. 42:201–205. 2011.In Chinese. PubMed/NCBI
|
|
32
|
Carracedo A and Pandolfi PP: The PTEN-PI3K
pathway: Of feedbacks and cross-talks. Oncogene. 27:5527–5541.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hühns M, Salem T, Schneider B, Krohn M,
Linnebacher M and Prall F: PTEN mutation, loss of heterozygosity,
promoter methylation and expression in colorectal carcinoma: Two
hits on the gene? Oncol Rep. 31:2236–2244. 2014.PubMed/NCBI
|
|
34
|
Kechagioglou P, Papi RM, Provatopoulou X,
Kalogera E, Papadimitriou E, Grigoropoulos P, Nonni A, Zografos G,
Kyriakidis DA and Gounaris A: Tumor suppressor PTEN in breast
cancer: Heterozygosity, mutations and protein expression.
Anticancer Res. 34:1387–1400. 2014.PubMed/NCBI
|
|
35
|
Mulholland DJ, Kobayashi N, Ruscetti M,
Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK
activation cooperate to promote EMT and metastasis initiated from
prostate cancer stem/progenitor cells. Cancer Res. 72:1878–1889.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang ZX, Lu BB, Wang H, Cheng ZX and Yin
YM: MicroRNA-21 modulates chemosensitivity of breast cancer cells
to doxorubicin by targeting PTEN. Arch Med Res. 42:281–290. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma F, Zhang J, Zhong L, Wang L, Liu Y,
Wang Y, Peng L and Guo B: Upregulated microRNA-301a in breast
cancer promotes tumor metastasis by targeting PTEN and activating
Wnt/β-catenin signaling. Gene. 535:191–197. 2014. View Article : Google Scholar
|
